Enanta Pharmaceuticals Chief Financial Officer Paul Mellett Dies

Dow Jones
09/03
 

By Colin Kellaher

 

Enanta Pharmaceuticals's long-time chief financial officer, Paul Mellett Jr., has died.

Mellett, who was 70 years old, joined Enanta as finance chief in 2003 and helped lead the Watertown, Mass., biotechnology company's initial public offering in 2013.

Enanta in late August said Harry Trout III, vice president of finance, would serve as interim principal financial officer and Kathleen Capps, executive director of accounting and controller, would step in as interim principal accounting officer while Mellett took a medical leave of absence.

 

Write to Colin Kellaher at colin.kellaher@wsj.com

 

(END) Dow Jones Newswires

September 03, 2025 06:24 ET (10:24 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10